Browse studies

Find your next paid study

4 recruiting studies matching your filters

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

This clinical trial studies eliminating surgery and/or radiation therapy in treating breast cancer patients. In HER2 positive and triple negative breast cancer…

Estrogen Receptor NegativeHER2 Positive Breast CarcinomaHER2/Neu Negative+9 more

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT02945579

Phase 1

Elacestrant in Advanced Triple Positive Breast Cancer, a Phase II Evaluation (ELATE)

The purpose of this study to assess the safety and efficacy of elacestrant, a selective estrogen receptor degrader (SERD) and dual biologic therapy, trastuzuma…

ER Positive, HER2 Positive Breast Cancer

Estimated

~$10 – $7,500

NYU Langone HealthNCT07612215

Phase 2

A Phase II Study of Induction Tucatinib and Trastuzumab With Total Neoadjuvant Therapy for Locally Advanced HER2-amplified Rectal Adenocarcinoma

The study researchers believe that a combination of the drugs trastuzumab and tucatinib, given with standard chemotherapy (capecitabine and oxaliplatin/FOLFOX)…

Adenocarcinoma of the RectumLocally Advanced Rectal AdenocarcinomaRectal Adenocarcinoma+2 more

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT05672524

Phase 2

Cancer CARE Beyond Walls - A Pilot of a Randomized, Pragmatic Trial of Cancer Directed Therapy Administration in the Patients' Homes Versus in Clinic

This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where i…

Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more